In adults, red blood cell production by bone marrow progenitors maintains the steady-state level of circulating cells. But during times of "stress," such as acute anemia, the erythropoietic response is predominantly generated by hematopoietic progenitors residing in the spleen, at least in mice. In both circumstances, erythropoietin (Epo) and SCF are the central regulators, albeit that compensatory circulating Epo levels are higher during recovery from acute anemia. The study of developmental hematopoiesis has revealed that fetal erythropoiesis and adult erythropoiesis occur in distinct anatomic sites and with distinct regulatory features (1, 2), and it has been suggested that adult splenic erythropoiesis more closely approximates fetal liver erythropoiesis than adult bone marrow erythropoiesis. Do these differences between steady-state erythropoietic regulation and the stress-induced erythropoietic response reflect differences in the erythroid progenitors in adult bone marrow versus spleen, differences in Epo/SCF signaling, the activity of other cytokines, or differences in the tissue microenvironment? In this issue of the JCI, Menon and coworkers provide evidence implicating the Epo receptor-activated (EpoR-activated) Stat5 signal as a unique contributor to the stress-induced erythropoietic response and thereby distinguishing homeostatic and stress-induced erythropoiesis at the level of EpoR signaling (3).
Following engagement of the EpoR, the preassociated tyrosine kinase Jak2 is activated, which then mediates phosphorylation of 8 conserved tyrosine motifs to generate phosphotyrosine (PY) recognition sites within the cytoplasmic tail of the EpoR (Figure 1 ). These PY sites serve to recruit both positive and negative regulators that effect erythroid progenitor expansion through both prosurvival and proliferative signals. (8) . Since these mutants were knocked in to the EpoR gene locus, this allows for physiologic mutant receptor expression in appropriate tissues and cells, in the absence of endogenous WT receptor expression. These mice were subjected to 3 stress conditions: phenylhydrazine-induced acute hemolytic anemia, acute anemia secondary to 5-fluorouracilinduced reduction in number of maturing erythroid progenitors, and anemia follow-ing bone marrow transplantation. In all 3 instances, despite normal, steady-state levels of circulating erythrocytes, EpoR-HM mice were incapable of appropriately responding to anemic stress, whereas EpoR-H mice responded in a manner similar to that of WT controls, suggesting that Stat5 is a critical regulator of stressinduced erythropoiesis, but not steadystate erythropoiesis (3). This is supported by the finding that some adult Stat5a,b -/-mice are also compromised in their response to phenylhydrazine-induced acute anemia (7) . A potential limitation of the present study is whether removal of the distal cytoplasmic tail of the EpoR, which has been shown to function as a negative regulatory domain (9) , might, in addition to Stat5, also contribute to the stress-induced erythropoietic response.
If Stat5 signals are uniquely critical for stress-induced erythropoiesis, then what is the nature of this signal? The authors looked at the induction of a group of known Epo-and Stat5-responsive genes (3). WT EpoR-and EpoR-H-containing primary erythroid progenitors induced expression of Pim-1 kinase, oncostatin-M, and SOCS-3 ( Figure 1 ), but, surprisingly, not Bcl-x, an antiapoptotic factor important for red blood cell survival (10), whose expression has been reported to be either decreased (5, 7) or unaffected in Stat5a,b -/-mice (6). This result raises the possibility that factors other than, or in addition to, Bcl-x are important for the survival of developing red blood cells. Since oncostatin-M has been suggested to contribute to erythroblast survival ( Figure 1 ). BMP4 is rapidly, and transiently, induced in the splenic red pulp (site of erythropoiesis) in response to acute anemia and was found to stimulate immature progenitors to give rise to Epo-responsive progenitors. Importantly, only spleen, not bone marrow, progenitors responded to BMP4 in ex vivo cultures. This result suggests that the spleen does indeed contain a unique erythropoietic microenvironment that may distinctly influence erythroid progenitors present therein. Likely, BMP4 expression will be induced in the spleen of both EpoR-HM and EpoR-H mice, since BMP4 transcription appears to be regulated by hypoxia-responsive elements (11) . Whether immature, Epo-nonresponsive splenic progenitors from EpoR-HM and EpoR-H mice differ in their response to BMP4 warrants testing, since BMP4 can affect CNS stem cell fate in a pathway activating Stat3 (13) . Finally, studies such as that of Menon et al. (3) highlight the importance of studying and disseminating genetically modi-fied mice with minimal or no steady-state phenotype. In many ways these mice could be viewed as models for otherwise normal adult humans who exhibit exaggerated or unexpected responses to inflammation, infectious agents, or cancer progression. As such, they have the potential to identify and dissect regulatory pathways that influence but do not cause disease.
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